Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530517 · ClinicalTrials.gov registry record · Phase 2
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
A Phase 2 study, sponsored by Zogenix.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00530517: Completed Phase 2 study, sponsored by Zogenix.
NCT00530517 is a Phase 2 study that has completed, run by Zogenix. The registered enrollment target is 54 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530517, a Phase 2 study, has completed, sponsored by Zogenix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
Intraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment. Study participation will last one month and include 2 doctor visits and 2-4 phone calls.
Interventions
- DEVICE Intraject Sumatriptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
What the finished NCT00530517 record still lists
NCT00530517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which Intraject Sumatriptan is the first listed.
NCT00530517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00530517 about?
NCT00530517 is a clinical study titled "A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack". Intraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment. Study participation will last one month and include 2 doctor visits and 2-4 phone calls.
What is the current status of trial NCT00530517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2007-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00530517?
The interventions under investigation include: Intraject Sumatriptan (DEVICE).
Who is sponsoring clinical trial NCT00530517?
This trial is sponsored by Zogenix, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00530517's enrollment target sits among peer trials
54 1160th of 2000 higher than 830 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia